IL314135A - Serpin peptides and methods of using the same - Google Patents
Serpin peptides and methods of using the sameInfo
- Publication number
- IL314135A IL314135A IL314135A IL31413524A IL314135A IL 314135 A IL314135 A IL 314135A IL 314135 A IL314135 A IL 314135A IL 31413524 A IL31413524 A IL 31413524A IL 314135 A IL314135 A IL 314135A
- Authority
- IL
- Israel
- Prior art keywords
- seraphine
- peptides
- methods
- seraphine peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263266444P | 2022-01-05 | 2022-01-05 | |
| PCT/US2022/082669 WO2023133078A2 (en) | 2022-01-05 | 2022-12-30 | Serpin peptides and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL314135A true IL314135A (en) | 2024-09-01 |
Family
ID=87074167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL314135A IL314135A (en) | 2022-01-05 | 2022-12-30 | Serpin peptides and methods of using the same |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20250161419A1 (https=) |
| EP (1) | EP4460322A4 (https=) |
| JP (1) | JP2025503607A (https=) |
| CN (1) | CN118804758A (https=) |
| AU (1) | AU2022431253A1 (https=) |
| CA (1) | CA3247129A1 (https=) |
| IL (1) | IL314135A (https=) |
| WO (1) | WO2023133078A2 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017040287A1 (en) * | 2015-08-28 | 2017-03-09 | Serpin Pharma, Llc | Methods for treatment of diseases |
| WO2017123401A1 (en) * | 2016-01-13 | 2017-07-20 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| EP3773727A4 (en) * | 2018-04-09 | 2022-05-04 | Yale University | BIFUNCTIONAL SMALL MOLECULES TO TARGETING THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS |
| KR20220099963A (ko) * | 2019-10-10 | 2022-07-14 | 예일 유니버시티 | 세포 수용체를 통한 분자 분해제로서의 조작된 항체 |
| US20210162029A1 (en) * | 2019-11-04 | 2021-06-03 | Azitra Inc | Compositions and methods for treatment or prevention of skin diseases and disorders with lekti |
| EP4003391A4 (en) * | 2020-07-06 | 2023-02-22 | Serpin Pharma, LLC | PEPTIDES AND METHODS OF USE THEREOF |
| AU2022222778A1 (en) * | 2021-02-22 | 2023-08-31 | Yale University | Targeted bifunctional degraders and methods using same |
-
2022
- 2022-12-30 IL IL314135A patent/IL314135A/en unknown
- 2022-12-30 JP JP2024540848A patent/JP2025503607A/ja active Pending
- 2022-12-30 CA CA3247129A patent/CA3247129A1/en active Pending
- 2022-12-30 EP EP22919262.0A patent/EP4460322A4/en active Pending
- 2022-12-30 US US18/726,945 patent/US20250161419A1/en active Pending
- 2022-12-30 AU AU2022431253A patent/AU2022431253A1/en active Pending
- 2022-12-30 WO PCT/US2022/082669 patent/WO2023133078A2/en not_active Ceased
- 2022-12-30 CN CN202280092284.4A patent/CN118804758A/zh active Pending
-
2023
- 2023-07-13 US US18/148,942 patent/US20230406906A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230406906A1 (en) | 2023-12-21 |
| AU2022431253A1 (en) | 2024-07-25 |
| WO2023133078A2 (en) | 2023-07-13 |
| CA3247129A1 (en) | 2023-07-13 |
| EP4460322A2 (en) | 2024-11-13 |
| US20250161419A1 (en) | 2025-05-22 |
| JP2025503607A (ja) | 2025-02-04 |
| CN118804758A (zh) | 2024-10-18 |
| EP4460322A4 (en) | 2026-02-25 |
| WO2023133078A3 (en) | 2023-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4232463T3 (da) | Interleukin-2-fc-fusionsproteiner og fremgangsmåder til anvendelses | |
| IL292871A (en) | Activatable cytokine polypeptides and methods of use thereof | |
| IL282177A (en) | Protein tyrosine-tyrosine analogs and methods of using the same | |
| IL292877A (en) | Angiotensinogen (agt) irna compositions and methods of use thereof | |
| EP4089115A4 (en) | Anti-tigit antibodies and usage method | |
| EP4472967A4 (en) | Iraqi Degradation Agents and Their Uses | |
| IL284661A (en) | Pcsk9 inhibitors and methods of use thereof | |
| DK3966206T3 (da) | Heteroarylaminopyrimidinamid-autophagihæmmere og fremgangsmåder til anvendelse deraf | |
| DK4186920T5 (da) | Ultra-langtidsvirkende insulin-fc-fusionsproteiner og fremgangsmåder til anvendelse | |
| IL285401A (en) | Anti-clec2d antibodies and methods of use thereof | |
| DK4267105T3 (da) | Antistofsammensætninger og fremgangsmåder til anvendelse deraf | |
| IL284683A (en) | Acute treatment and rapid treatment of headache using anti-cgrp antibodies | |
| DK4073098T3 (da) | Ultralangtidsvirkende insulin-Fc-fusionsproteiner og fremgangsmåder til anvendelse | |
| DK4200018T3 (da) | Anti-par-2-antistoffer og fremgangsmåder til anvendelse deraf | |
| IL288310A (en) | Cot modulators and methods of use thereof | |
| EP4069274A4 (en) | PEPTIDE CONJUGATES AND METHODS OF USE | |
| EP4499068A4 (en) | Iraqi Degradation Agents and Their Uses | |
| EP4499149A4 (en) | PROTEIN DEGRADING AGENTS AND THEIR USES | |
| IL311301A (en) | Anti-siglec-6 antibodies and methods of use thereof | |
| IL286485A (en) | Pi4-kinase inhibitors and methods of using the same | |
| DK4288456T3 (da) | Anti-met-antistoffer og anvendelser deraf | |
| IL284880A (en) | Liver-specific inducible promoters and methods of use thereof | |
| IL314048A (en) | Anti-alk1 antibodies and methods of using the same | |
| IL311234A (en) | Novel combinations of antibodies and uses thereof | |
| IL289431A (en) | Recombinant sialidases and methods of using the same |